Eigen RadarScience
Analysis

Microgel assemblies carry antibodies into cultured cells

Engineered antibodies formed gel-like clusters that entered cultured cells and released their cargo into the surrounding cell fluid. The peer-reviewed study linked delivery to the clusters’ stability, flexibility and interaction with the cell membrane. Delivered antibodies retained target recognition; another cell experiment reduced recruitment of a protein to stress granules. The work remains at the laboratory-cell stage.

Science··Evening
Low-angle wide view of a bright cell-biology imaging room with an inverted live-cell microscope holding a multi-well cell-culture dish, beside unmarked vials of microgel suspension and transparent culture flasks.

Antibody clusters cross the cell boundary

A peer-reviewed cell-culture study used microgels, tiny assemblies with gel-like properties, to carry antibodies into the fluid inside cells. Antibodies normally have difficulty crossing the cell membrane. Researchers altered antibody chains and combined them with a peptide, a short protein fragment that affects membrane permeability. The resulting assemblies remained stable under physiological salt conditions while preserving the antibodies’ ability to recognise their targets.[1]

Imaging follows wrapping and release

Live-cell imaging showed the membrane extending around the clusters, supported by the cell’s actin framework. Antibody then dispersed rapidly into the cytosol, the fluid outside the nucleus. Some cells instead retained antibody in small compartments. Tests that altered actin function or membrane cholesterol reduced delivery. The assemblies’ stiffness also mattered: the most rigid version did not provide the strongest delivery.[1]

Delivered antibodies act on an intracellular target

Delivered antibody bound an experimental target inside cells. In another experiment, an antibody against TDP-43, a protein implicated in neurodegenerative disease, reduced its recruitment to stress granules during chemically induced stress. Those findings came from cultured cells. Animal distribution, long-term safety and clinical benefit were outside the study, which examined delivery and cellular effects rather than treatment outcomes in people.[1]

References

  1. News sourceNature CommunicationsMicrogel assemblies rapidly delivered antibodies into cells↩1↩2↩3